➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
Baxter
McKesson
Merck

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Surotomycin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Surotomycin?

Surotomycin is an investigational drug.

There have been 4 clinical trials for Surotomycin. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Diarrhea and [disabled in preview]. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Cubist Pharmaceuticals LLC, and [disabled in preview].

There are eight US patents protecting this investigational drug and thirty-eight international patents.

Recent Clinical Trials for Surotomycin
TitleSponsorPhase
Study of CB-183,315 in Patients With Clostridium Difficile Associated DiarrheaCubist Pharmaceuticals LLCPhase 3
A Study of CB-183,315 in Patients With Clostridium Difficile Associated DiarrheaCubist Pharmaceuticals LLCPhase 3
A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)Merck Sharp & Dohme Corp.Phase 1

See all Surotomycin clinical trials

Clinical Trial Summary for Surotomycin

Top disease conditions for Surotomycin
Top clinical trial sponsors for Surotomycin

See all Surotomycin clinical trials

US Patents for Surotomycin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Surotomycin ⤷  Try it Free Compounds and methods of treating infections NEOCULI PTY LTD (Victoria, AU) ⤷  Try it Free
Surotomycin ⤷  Try it Free Compounds and methods of treating infections NEOCULI PTY LTD (Victoria, AU) ⤷  Try it Free
Surotomycin ⤷  Try it Free Nanoparticles with protected interiors, and methods of use thereof Universidade de Santiago de Compostela (Santiago de Compostela, ES) ⤷  Try it Free
Surotomycin ⤷  Try it Free Compounds and methods of treating bacterial infections Ultupharma AB (Uppsala, SE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Surotomycin

Drugname Country Document Number Estimated Expiration Related US Patent
Surotomycin Australia AU2014262129 2033-05-01 ⤷  Try it Free
Surotomycin Australia AU2019200080 2033-05-01 ⤷  Try it Free
Surotomycin Brazil BR112015027704 2033-05-01 ⤷  Try it Free
Surotomycin Canada CA2910756 2033-05-01 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.